Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles J Shoemaker

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Molecular Therapy. Methods & Clinical Development|April 17, 2020
Nanoplasmid Vectors Co-expressing Innate Immune Agonists Enhance DNA Vaccines for Venezuelan Equine Encephalitis Virus and Ebola VirusJohn J Suschak, Lesley C Dupuy, Charles J Shoemaker, et al.
Journal of Virology|January 2, 2015
Ebola virus and severe acute respiratory syndrome coronavirus display late cell entry kinetics: evidence that transport to NPC1+ endolysosomes is a rate-defining stepRebecca M Mingo, James A Simmons, Charles J Shoemaker, et al.
Journal of Virological Methods|April 19, 2019
Development of a bead-based immunoassay using virus-like particles for detection of alphaviral humoral responseKeersten M Ricks, Charles J Shoemaker, Lesley C Dupuy, et al.
Journal of Virology|June 10, 2016
Mapping of Ebolavirus Neutralization by Monoclonal Antibodies in the ZMapp Cocktail Using Cryo-Electron Tomography and Studies of Cellular EntryErin E H Tran, Elizabeth A Nelson, Pranay Bonagiri, et al.
NPJ Vaccines|April 23, 2022
A DNA vaccine targeting VEE virus delivered by needle-free jet-injection protects macaques against aerosol challengeJohn J Suschak, Sandra L Bixler, Catherine V Badger, et al.
Journal of Virology|August 17, 2018
Exploring Crimean-Congo Hemorrhagic Fever Virus-Induced Hepatic Injury Using Antibody-Mediated Type I Interferon Blockade in MiceMichael E Lindquist, Xiankun Zeng, Louis A Altamura, et al.
Plos Pathogens|May 19, 2022
The host inflammatory response contributes to disease severity in Crimean-Congo hemorrhagic fever virus infected miceJoseph W Golden, Xiankun Zeng, Curtis R Cline, et al.
Science Translational Medicine|June 21, 2013
FDA-approved selective estrogen receptor modulators inhibit Ebola virus infectionLisa M Johansen, Jennifer M Brannan, Sue E Delos, et al.
Viruses|May 27, 2026
Dynamic Changes in Host Immune Response During Crimean-Congo Hemorrhagic Fever and Severe Fever with Thrombocytopenia Syndrome in MiceDoreswamy Kenchegowda, Brian D Carey, Joshua Shamblin, et al.
Plos Neglected Tropical Diseases|September 19, 2017
A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse modelsAura R Garrison, Charles J Shoemaker, Joseph W Golden, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Molecular Therapy. Methods & Clinical Development|April 17, 2020
Nanoplasmid Vectors Co-expressing Innate Immune Agonists Enhance DNA Vaccines for Venezuelan Equine Encephalitis Virus and Ebola VirusJohn J Suschak, Lesley C Dupuy, Charles J Shoemaker, et al.
Journal of Virology|January 2, 2015
Ebola virus and severe acute respiratory syndrome coronavirus display late cell entry kinetics: evidence that transport to NPC1+ endolysosomes is a rate-defining stepRebecca M Mingo, James A Simmons, Charles J Shoemaker, et al.
Journal of Virological Methods|April 19, 2019
Development of a bead-based immunoassay using virus-like particles for detection of alphaviral humoral responseKeersten M Ricks, Charles J Shoemaker, Lesley C Dupuy, et al.
Journal of Virology|June 10, 2016
Mapping of Ebolavirus Neutralization by Monoclonal Antibodies in the ZMapp Cocktail Using Cryo-Electron Tomography and Studies of Cellular EntryErin E H Tran, Elizabeth A Nelson, Pranay Bonagiri, et al.
NPJ Vaccines|April 23, 2022
A DNA vaccine targeting VEE virus delivered by needle-free jet-injection protects macaques against aerosol challengeJohn J Suschak, Sandra L Bixler, Catherine V Badger, et al.
Journal of Virology|August 17, 2018
Exploring Crimean-Congo Hemorrhagic Fever Virus-Induced Hepatic Injury Using Antibody-Mediated Type I Interferon Blockade in MiceMichael E Lindquist, Xiankun Zeng, Louis A Altamura, et al.
Plos Pathogens|May 19, 2022
The host inflammatory response contributes to disease severity in Crimean-Congo hemorrhagic fever virus infected miceJoseph W Golden, Xiankun Zeng, Curtis R Cline, et al.
Science Translational Medicine|June 21, 2013
FDA-approved selective estrogen receptor modulators inhibit Ebola virus infectionLisa M Johansen, Jennifer M Brannan, Sue E Delos, et al.
Viruses|May 27, 2026
Dynamic Changes in Host Immune Response During Crimean-Congo Hemorrhagic Fever and Severe Fever with Thrombocytopenia Syndrome in MiceDoreswamy Kenchegowda, Brian D Carey, Joshua Shamblin, et al.
Plos Neglected Tropical Diseases|September 19, 2017
A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse modelsAura R Garrison, Charles J Shoemaker, Joseph W Golden, et al.
Pageof 4